查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1874241

異亮胺酸：全球市佔率及排名、總收入及需求預測（2025-2031年）

Isoleucine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024年全球異亮胺酸市場規模估計為2.36億美元，預計到2031年將達到3.99億美元，2025年至2031年的複合年成長率為7.5%。

本報告對近期異亮氨酸關稅調整和國際戰略反制措施進行了全面評估，評估內容包括跨境產業佈局、資本配置模式、區域經濟相互依存關係以及供應鏈重組。

異亮氨酸與亮氨酸和纈氨酸一樣，是人體必需的支鏈胺基酸（BCAA）。它在肌肉代謝、耐力、組織修復和血糖值調節中發揮重要作用。由於人體無法自行合成，因此必須從飲食或補充劑中取得。

全球異亮胺酸市場的主要企業包括味之素株式會社、協和發酵工業株式會社和贏創株式會社。前三大公司佔了全球約60%的市場。中國和日本是主要市場，兩者合計約佔全球市場佔有率的60%。 GMP級產品是主要類型，約佔市場佔有率的50%。醫藥應用是主要應用領域，約佔市場佔有率的50%。亞洲（尤其是中國、日本和韓國）、北美和歐洲是主要區域市場。中國已成為重要的生產基地，擁有完整的產業鍊和原料優勢。

受以下因素驅動，全球異亮胺酸市場正經歷穩定成長：

運動營養和機能性食品的需求不斷成長，尤其是在健身愛好者和耐力運動員中。

在醫學營養領域（特別是用於治療肝病和代謝性疾病的特殊醫學食品）的應用日益廣泛

對高品質飼料添加劑（尤其是豬和家禽飼料添加劑）的需求不斷成長

在生物製藥領域，尤其是在重組蛋白生產方面的應用日益廣泛

市場趨勢：

植物來源亮氨酸的需求不斷成長：受素食主義和永續性趨勢的推動。

個人化營養的成長：老年人、糖尿病患者和運動員對定製配方的需求不斷成長。

技術創新：生物發酵和綠色合成技術提高了純度和生產效率。

拓展跨學科應用：除了傳統領域外，異亮氨酸擴大用於生物聚合物和新型功能材料。

競爭格局：

市場集中度高：市場由少數幾家來自中國和日本等國家的大型公司主導。

成本控制是一個關鍵因素：原料（葡萄糖、氮源）和能源價格的波動對生產者有重大影響。

品牌推廣和分銷領域的競爭日益激烈：國際市場要求品質認證（ISO、清真、猶太潔食認證）和穩定的供應鏈。

新參與企業挑戰現狀：來自歐洲、美國和印度的新參與企業正在挑戰亞洲的壟斷地位。

市場挑戰：

原料價格（玉米、葡萄糖）的波動增加了生產成本的不確定性。

加強貿易壁壘和環境法規，特別是針對中國產品在美國和歐盟提起的反傾銷訴訟。

高階應用領域，例如醫藥級產品，對純度和安全標準要求較高，因此存在很高的技術障礙。

產能過剩風險：生產過度擴張，尤其是在中國，可能導致價格戰。

本報告旨在對全球異亮氨酸市場依地區/國家、類型和應用進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

本報告以2024年為基準年，提供異亮胺酸市場規模、估計值和預測，單位為銷售量（噸）和收入（百萬美元），並包含2020年至2031年的歷史數據和預測數據。定量和定性分析將幫助讀者制定異亮氨酸業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • Ajinomoto
  • Kyowa Hakko
  • Amino GmbH
  • Fufeng Group
  • Yichang SanXia Proudin Biopharmaceutical
  • Wuxi Jinghai Amino Acid
  • Meihua Group
  • Jiahe Biological Technology
  • Hubei Bafeng Pharmaceutical

依類型分類的區隔市場

  • 醫藥級
  • 食品級
  • 飼料級

應用領域

  • 製藥
  • 運動營養
  • 食品/飲料
  • 動物營養
  • 其他

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Isoleucine was estimated to be worth US$ 236 million in 2024 and is forecast to a readjusted size of US$ 399 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Isoleucine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Isoleucine is an essential branched-chain amino acid (BCAA), along with leucine and valine. It plays a vital role in muscle metabolism, endurance enhancement, tissue repair, and blood sugar regulation. As the human body cannot synthesize it naturally, isoleucine must be obtained through dietary sources or supplements.

The major players in global Isoleucine market include Ajinomoto, Kyowa Hakko, Evonik, etc. The top 3 players occupy about 60% shares of the global market. China and Japan are main markets, they occupy about 60% of the global market. GMP Grade is the main type, with a share about 50%. Pharmaceutical is the main application, which holds a share about 50%.Asia (particularly China, Japan, and South Korea), North America, and Europe are the key regional markets. China has become a vital production hub with a complete industrial chain and raw material advantages.

The global isoleucine market is steadily growing, driven by:

Rising demand for sports nutrition and functional foods (particularly among fitness enthusiasts and endurance athletes)

Increasing use in medical nutrition (especially for special medical foods for liver and metabolic diseases)

Growing demand in high-grade animal feed additives (especially for pigs and poultry)

Expanding applications in the biopharmaceutical sector, especially in recombinant protein production

Market Trends:

Rising Demand for Plant-based Isoleucine: Driven by veganism and sustainability trends.

Personalized Nutrition Growth: Increasing demand for customized formulas for elderly, diabetic patients, and athletes.

Technological Innovations: Bio-fermentation and green synthesis technologies enhance purity and production efficiency.

Cross-sector Applications Expansion: Isoleucine usage is growing in biopolymers and novel functional materials beyond traditional sectors.

Competitive Landscape:

High Market Concentration: Dominated by a few large players from countries like China and Japan.

Cost Control as Key Factor: Raw material (glucose, nitrogen sources) and energy price fluctuations greatly impact producers.

Intensified Competition in Branding and Distribution: International markets demand quality certifications (ISO, HALAL, KOSHER) and stable supply chains.

Emerging Entrants Challenging Existing Order: Some new players from Europe, the US, and India are entering to disrupt the Asian monopoly.

Market Challenges:

Raw Material Price Volatility (corn, glucose) increases production cost uncertainties

Trade Barriers and Environmental Regulations intensify, especially anti-dumping cases against Chinese products in the US/EU

High Technical Barriers for Premium Applications, such as pharmaceutical-grade products requiring higher purity and safety standards

Overcapacity Risk: Especially in China, where excessive production expansion may lead to price wars

This report aims to provide a comprehensive presentation of the global market for Isoleucine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Isoleucine by region & country, by Type, and by Application.

The Isoleucine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isoleucine.

Market Segmentation

By Company

  • Ajinomoto
  • Kyowa Hakko
  • Amino GmbH
  • Fufeng Group
  • Yichang SanXia Proudin Biopharmaceutical
  • Wuxi Jinghai Amino Acid
  • Meihua Group
  • Jiahe Biological Technology
  • Hubei Bafeng Pharmaceutical

Segment by Type

  • Pharma Grade
  • Food Grade
  • Feed Grade

Segment by Application

  • Pharmaceutical
  • Sports Nutrition
  • Food & Beverages
  • Animal Nutrition
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Isoleucine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Isoleucine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Isoleucine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Isoleucine Product Introduction
  • 1.2 Global Isoleucine Market Size Forecast
    • 1.2.1 Global Isoleucine Sales Value (2020-2031)
    • 1.2.2 Global Isoleucine Sales Volume (2020-2031)
    • 1.2.3 Global Isoleucine Sales Price (2020-2031)
  • 1.3 Isoleucine Market Trends & Drivers
    • 1.3.1 Isoleucine Industry Trends
    • 1.3.2 Isoleucine Market Drivers & Opportunity
    • 1.3.3 Isoleucine Market Challenges
    • 1.3.4 Isoleucine Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Isoleucine Players Revenue Ranking (2024)
  • 2.2 Global Isoleucine Revenue by Company (2020-2025)
  • 2.3 Global Isoleucine Players Sales Volume Ranking (2024)
  • 2.4 Global Isoleucine Sales Volume by Company Players (2020-2025)
  • 2.5 Global Isoleucine Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Isoleucine Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Isoleucine Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Isoleucine
  • 2.9 Isoleucine Market Competitive Analysis
    • 2.9.1 Isoleucine Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Isoleucine Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoleucine as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Pharma Grade
    • 3.1.2 Food Grade
    • 3.1.3 Feed Grade
  • 3.2 Global Isoleucine Sales Value by Type
    • 3.2.1 Global Isoleucine Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Isoleucine Sales Value, by Type (2020-2031)
    • 3.2.3 Global Isoleucine Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Isoleucine Sales Volume by Type
    • 3.3.1 Global Isoleucine Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Isoleucine Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Isoleucine Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Isoleucine Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Pharmaceutical
    • 4.1.2 Sports Nutrition
    • 4.1.3 Food & Beverages
    • 4.1.4 Animal Nutrition
    • 4.1.5 Others
  • 4.2 Global Isoleucine Sales Value by Application
    • 4.2.1 Global Isoleucine Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Isoleucine Sales Value, by Application (2020-2031)
    • 4.2.3 Global Isoleucine Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Isoleucine Sales Volume by Application
    • 4.3.1 Global Isoleucine Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Isoleucine Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Isoleucine Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Isoleucine Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Isoleucine Sales Value by Region
    • 5.1.1 Global Isoleucine Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Isoleucine Sales Value by Region (2020-2025)
    • 5.1.3 Global Isoleucine Sales Value by Region (2026-2031)
    • 5.1.4 Global Isoleucine Sales Value by Region (%), (2020-2031)
  • 5.2 Global Isoleucine Sales Volume by Region
    • 5.2.1 Global Isoleucine Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Isoleucine Sales Volume by Region (2020-2025)
    • 5.2.3 Global Isoleucine Sales Volume by Region (2026-2031)
    • 5.2.4 Global Isoleucine Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Isoleucine Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Isoleucine Sales Value, 2020-2031
    • 5.4.2 North America Isoleucine Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Isoleucine Sales Value, 2020-2031
    • 5.5.2 Europe Isoleucine Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Isoleucine Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Isoleucine Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Isoleucine Sales Value, 2020-2031
    • 5.7.2 South America Isoleucine Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Isoleucine Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Isoleucine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Isoleucine Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Isoleucine Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Isoleucine Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Isoleucine Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Isoleucine Sales Value, 2020-2031
    • 6.3.2 United States Isoleucine Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Isoleucine Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Isoleucine Sales Value, 2020-2031
    • 6.4.2 Europe Isoleucine Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Isoleucine Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Isoleucine Sales Value, 2020-2031
    • 6.5.2 China Isoleucine Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Isoleucine Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Isoleucine Sales Value, 2020-2031
    • 6.6.2 Japan Isoleucine Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Isoleucine Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Isoleucine Sales Value, 2020-2031
    • 6.7.2 South Korea Isoleucine Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Isoleucine Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Isoleucine Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Isoleucine Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Isoleucine Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Isoleucine Sales Value, 2020-2031
    • 6.9.2 India Isoleucine Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Isoleucine Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Ajinomoto
    • 7.1.1 Ajinomoto Company Information
    • 7.1.2 Ajinomoto Introduction and Business Overview
    • 7.1.3 Ajinomoto Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Ajinomoto Isoleucine Product Offerings
    • 7.1.5 Ajinomoto Recent Development
  • 7.2 Kyowa Hakko
    • 7.2.1 Kyowa Hakko Company Information
    • 7.2.2 Kyowa Hakko Introduction and Business Overview
    • 7.2.3 Kyowa Hakko Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Kyowa Hakko Isoleucine Product Offerings
    • 7.2.5 Kyowa Hakko Recent Development
  • 7.3 Amino GmbH
    • 7.3.1 Amino GmbH Company Information
    • 7.3.2 Amino GmbH Introduction and Business Overview
    • 7.3.3 Amino GmbH Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Amino GmbH Isoleucine Product Offerings
    • 7.3.5 Amino GmbH Recent Development
  • 7.4 Fufeng Group
    • 7.4.1 Fufeng Group Company Information
    • 7.4.2 Fufeng Group Introduction and Business Overview
    • 7.4.3 Fufeng Group Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Fufeng Group Isoleucine Product Offerings
    • 7.4.5 Fufeng Group Recent Development
  • 7.5 Yichang SanXia Proudin Biopharmaceutical
    • 7.5.1 Yichang SanXia Proudin Biopharmaceutical Company Information
    • 7.5.2 Yichang SanXia Proudin Biopharmaceutical Introduction and Business Overview
    • 7.5.3 Yichang SanXia Proudin Biopharmaceutical Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Yichang SanXia Proudin Biopharmaceutical Isoleucine Product Offerings
    • 7.5.5 Yichang SanXia Proudin Biopharmaceutical Recent Development
  • 7.6 Wuxi Jinghai Amino Acid
    • 7.6.1 Wuxi Jinghai Amino Acid Company Information
    • 7.6.2 Wuxi Jinghai Amino Acid Introduction and Business Overview
    • 7.6.3 Wuxi Jinghai Amino Acid Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Wuxi Jinghai Amino Acid Isoleucine Product Offerings
    • 7.6.5 Wuxi Jinghai Amino Acid Recent Development
  • 7.7 Meihua Group
    • 7.7.1 Meihua Group Company Information
    • 7.7.2 Meihua Group Introduction and Business Overview
    • 7.7.3 Meihua Group Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Meihua Group Isoleucine Product Offerings
    • 7.7.5 Meihua Group Recent Development
  • 7.8 Jiahe Biological Technology
    • 7.8.1 Jiahe Biological Technology Company Information
    • 7.8.2 Jiahe Biological Technology Introduction and Business Overview
    • 7.8.3 Jiahe Biological Technology Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Jiahe Biological Technology Isoleucine Product Offerings
    • 7.8.5 Jiahe Biological Technology Recent Development
  • 7.9 Hubei Bafeng Pharmaceutical
    • 7.9.1 Hubei Bafeng Pharmaceutical Company Information
    • 7.9.2 Hubei Bafeng Pharmaceutical Introduction and Business Overview
    • 7.9.3 Hubei Bafeng Pharmaceutical Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Hubei Bafeng Pharmaceutical Isoleucine Product Offerings
    • 7.9.5 Hubei Bafeng Pharmaceutical Recent Development

8 Industry Chain Analysis

  • 8.1 Isoleucine Industrial Chain
  • 8.2 Isoleucine Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Isoleucine Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Isoleucine Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Isoleucine Market Trends
  • Table 2. Isoleucine Market Drivers & Opportunity
  • Table 3. Isoleucine Market Challenges
  • Table 4. Isoleucine Market Restraints
  • Table 5. Global Isoleucine Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Isoleucine Revenue Market Share by Company (2020-2025)
  • Table 7. Global Isoleucine Sales Volume by Company (2020-2025) & (Tons)
  • Table 8. Global Isoleucine Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Isoleucine Price by Company (2020-2025) & (US$/Ton)
  • Table 10. Key Manufacturers Isoleucine Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Isoleucine Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Isoleucine
  • Table 13. Global Isoleucine Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoleucine as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Isoleucine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Isoleucine Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Isoleucine Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Isoleucine Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Isoleucine Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Isoleucine Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
  • Table 22. Global Isoleucine Sales Volume by Type (2020-2025) & (Tons)
  • Table 23. Global Isoleucine Sales Volume by Type (2026-2031) & (Tons)
  • Table 24. Global Isoleucine Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Isoleucine Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Isoleucine Price by Type (2020-2025) & (US$/Ton)
  • Table 27. Global Isoleucine Price by Type (2026-2031) & (US$/Ton)
  • Table 28. Global Isoleucine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Isoleucine Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Isoleucine Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Isoleucine Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Isoleucine Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Isoleucine Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
  • Table 34. Global Isoleucine Sales Volume by Application (2020-2025) & (Tons)
  • Table 35. Global Isoleucine Sales Volume by Application (2026-2031) & (Tons)
  • Table 36. Global Isoleucine Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Isoleucine Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Isoleucine Price by Application (2020-2025) & (US$/Ton)
  • Table 39. Global Isoleucine Price by Application (2026-2031) & (US$/Ton)
  • Table 40. Global Isoleucine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Isoleucine Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Isoleucine Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Isoleucine Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Isoleucine Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Isoleucine Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
  • Table 46. Global Isoleucine Sales Volume by Region (2020-2025) & (Tons)
  • Table 47. Global Isoleucine Sales Volume by Region (2026-2031) & (Tons)
  • Table 48. Global Isoleucine Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Isoleucine Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Isoleucine Average Price by Region (2020-2025) & (US$/Ton)
  • Table 51. Global Isoleucine Average Price by Region (2026-2031) & (US$/Ton)
  • Table 52. Key Countries/Regions Isoleucine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Isoleucine Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Isoleucine Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Isoleucine Sales Volume, (2020-2025) & (Tons)
  • Table 56. Key Countries/Regions Isoleucine Sales Volume, (2026-2031) & (Tons)
  • Table 57. Ajinomoto Company Information
  • Table 58. Ajinomoto Introduction and Business Overview
  • Table 59. Ajinomoto Isoleucine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 60. Ajinomoto Isoleucine Product Offerings
  • Table 61. Ajinomoto Recent Development
  • Table 62. Kyowa Hakko Company Information
  • Table 63. Kyowa Hakko Introduction and Business Overview
  • Table 64. Kyowa Hakko Isoleucine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 65. Kyowa Hakko Isoleucine Product Offerings
  • Table 66. Kyowa Hakko Recent Development
  • Table 67. Amino GmbH Company Information
  • Table 68. Amino GmbH Introduction and Business Overview
  • Table 69. Amino GmbH Isoleucine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 70. Amino GmbH Isoleucine Product Offerings
  • Table 71. Amino GmbH Recent Development
  • Table 72. Fufeng Group Company Information
  • Table 73. Fufeng Group Introduction and Business Overview
  • Table 74. Fufeng Group Isoleucine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 75. Fufeng Group Isoleucine Product Offerings
  • Table 76. Fufeng Group Recent Development
  • Table 77. Yichang SanXia Proudin Biopharmaceutical Company Information
  • Table 78. Yichang SanXia Proudin Biopharmaceutical Introduction and Business Overview
  • Table 79. Yichang SanXia Proudin Biopharmaceutical Isoleucine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 80. Yichang SanXia Proudin Biopharmaceutical Isoleucine Product Offerings
  • Table 81. Yichang SanXia Proudin Biopharmaceutical Recent Development
  • Table 82. Wuxi Jinghai Amino Acid Company Information
  • Table 83. Wuxi Jinghai Amino Acid Introduction and Business Overview
  • Table 84. Wuxi Jinghai Amino Acid Isoleucine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 85. Wuxi Jinghai Amino Acid Isoleucine Product Offerings
  • Table 86. Wuxi Jinghai Amino Acid Recent Development
  • Table 87. Meihua Group Company Information
  • Table 88. Meihua Group Introduction and Business Overview
  • Table 89. Meihua Group Isoleucine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 90. Meihua Group Isoleucine Product Offerings
  • Table 91. Meihua Group Recent Development
  • Table 92. Jiahe Biological Technology Company Information
  • Table 93. Jiahe Biological Technology Introduction and Business Overview
  • Table 94. Jiahe Biological Technology Isoleucine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 95. Jiahe Biological Technology Isoleucine Product Offerings
  • Table 96. Jiahe Biological Technology Recent Development
  • Table 97. Hubei Bafeng Pharmaceutical Company Information
  • Table 98. Hubei Bafeng Pharmaceutical Introduction and Business Overview
  • Table 99. Hubei Bafeng Pharmaceutical Isoleucine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 100. Hubei Bafeng Pharmaceutical Isoleucine Product Offerings
  • Table 101. Hubei Bafeng Pharmaceutical Recent Development
  • Table 102. Key Raw Materials Lists
  • Table 103. Raw Materials Key Suppliers Lists
  • Table 104. Isoleucine Downstream Customers
  • Table 105. Isoleucine Distributors List
  • Table 106. Research Programs/Design for This Report
  • Table 107. Key Data Information from Secondary Sources
  • Table 108. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Isoleucine Product Picture
  • Figure 2. Global Isoleucine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Isoleucine Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Isoleucine Sales Volume (2020-2031) & (Tons)
  • Figure 5. Global Isoleucine Sales Price (2020-2031) & (US$/Ton)
  • Figure 6. Isoleucine Report Years Considered
  • Figure 7. Global Isoleucine Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Isoleucine Players Sales Volume Ranking (2024) & (Tons)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Isoleucine Revenue in 2024
  • Figure 10. Isoleucine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Pharma Grade Picture
  • Figure 12. Food Grade Picture
  • Figure 13. Feed Grade Picture
  • Figure 14. Global Isoleucine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Isoleucine Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Isoleucine Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
  • Figure 17. Global Isoleucine Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Isoleucine Price by Type (2020-2031) & (US$/Ton)
  • Figure 19. Product Picture of Pharmaceutical
  • Figure 20. Product Picture of Sports Nutrition
  • Figure 21. Product Picture of Food & Beverages
  • Figure 22. Product Picture of Animal Nutrition
  • Figure 23. Product Picture of Others
  • Figure 24. Global Isoleucine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 25. Global Isoleucine Sales Value Market Share by Application, 2024 & 2031
  • Figure 26. Global Isoleucine Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
  • Figure 27. Global Isoleucine Sales Volume Market Share by Application, 2024 & 2031
  • Figure 28. Global Isoleucine Price by Application (2020-2031) & (US$/Ton)
  • Figure 29. North America Isoleucine Sales Value (2020-2031) & (US$ Million)
  • Figure 30. North America Isoleucine Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Europe Isoleucine Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Isoleucine Sales Value by Country (%), 2024 VS 2031
  • Figure 33. Asia Pacific Isoleucine Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Asia Pacific Isoleucine Sales Value by Region (%), 2024 VS 2031
  • Figure 35. South America Isoleucine Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. South America Isoleucine Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Middle East & Africa Isoleucine Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Middle East & Africa Isoleucine Sales Value by Country (%), 2024 VS 2031
  • Figure 39. Key Countries/Regions Isoleucine Sales Value (%), (2020-2031)
  • Figure 40. Key Countries/Regions Isoleucine Sales Volume (%), (2020-2031)
  • Figure 41. United States Isoleucine Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. United States Isoleucine Sales Value by Type (%), 2024 VS 2031
  • Figure 43. United States Isoleucine Sales Value by Application (%), 2024 VS 2031
  • Figure 44. Europe Isoleucine Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Europe Isoleucine Sales Value by Type (%), 2024 VS 2031
  • Figure 46. Europe Isoleucine Sales Value by Application (%), 2024 VS 2031
  • Figure 47. China Isoleucine Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. China Isoleucine Sales Value by Type (%), 2024 VS 2031
  • Figure 49. China Isoleucine Sales Value by Application (%), 2024 VS 2031
  • Figure 50. Japan Isoleucine Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. Japan Isoleucine Sales Value by Type (%), 2024 VS 2031
  • Figure 52. Japan Isoleucine Sales Value by Application (%), 2024 VS 2031
  • Figure 53. South Korea Isoleucine Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. South Korea Isoleucine Sales Value by Type (%), 2024 VS 2031
  • Figure 55. South Korea Isoleucine Sales Value by Application (%), 2024 VS 2031
  • Figure 56. Southeast Asia Isoleucine Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. Southeast Asia Isoleucine Sales Value by Type (%), 2024 VS 2031
  • Figure 58. Southeast Asia Isoleucine Sales Value by Application (%), 2024 VS 2031
  • Figure 59. India Isoleucine Sales Value, (2020-2031) & (US$ Million)
  • Figure 60. India Isoleucine Sales Value by Type (%), 2024 VS 2031
  • Figure 61. India Isoleucine Sales Value by Application (%), 2024 VS 2031
  • Figure 62. Isoleucine Industrial Chain
  • Figure 63. Isoleucine Manufacturing Cost Structure
  • Figure 64. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 65. Bottom-up and Top-down Approaches for This Report
  • Figure 66. Data Triangulation
  • Figure 67. Key Executives Interviewed